These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 8714023
1. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea. Akerlund M, Melin P, Maggi M. Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023 [Abstract] [Full Text] [Related]
2. Vasopressin and oxytocin in normal reproduction and in the pathophysiology of preterm labour and primary dysmenorrhoea. Development of receptor antagonists for therapeutic use in these conditions. Akerlund M. Rocz Akad Med Bialymst; 2004; 49():18-21. PubMed ID: 15631309 [Abstract] [Full Text] [Related]
3. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor. Chan WY, Wo NC, Cheng LL, Manning M. J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583 [Abstract] [Full Text] [Related]
4. Barusiban suppresses oxytocin-induced preterm labour in non-human primates. Reinheimer TM. BMC Pregnancy Childbirth; 2007 Jun 01; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159 [Abstract] [Full Text] [Related]
6. Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea. Akerlund M. Prog Brain Res; 2002 Jun 01; 139():359-65. PubMed ID: 12436949 [Abstract] [Full Text] [Related]
7. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women. Akerlund M, Bossmar T, Brouard R, Kostrzewska A, Laudanski T, Lemancewicz A, Serradeil-Le Gal C, Steinwall M. Br J Obstet Gynaecol; 1999 Oct 01; 106(10):1047-53. PubMed ID: 10519430 [Abstract] [Full Text] [Related]
8. The role of oxytocin receptors and vasopressin V1a receptors in uterine contractions in rats: implications for tocolytic therapy with oxytocin antagonists. Chan WY, Wo NC, Manning M. Am J Obstet Gynecol; 1996 Nov 01; 175(5):1331-5. PubMed ID: 8942510 [Abstract] [Full Text] [Related]
9. Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women. Bossmar T, Akerlund M, Szamatowicz J, Laudanski T, Fantoni G, Maggi M. Br J Obstet Gynaecol; 1995 Nov 01; 102(11):907-12. PubMed ID: 8534628 [Abstract] [Full Text] [Related]
10. Oxytocin receptor antagonists. Update. Goodwin TM, Zograbyan A. Clin Perinatol; 1998 Dec 01; 25(4):859-71, vi. PubMed ID: 9891619 [Abstract] [Full Text] [Related]
14. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G. Prog Brain Res; 2008 Dec 01; 170():473-512. PubMed ID: 18655903 [Abstract] [Full Text] [Related]
19. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists. Manning M, Cheng LL, Klis WA, Balaspiri L, Olma A, Sawyer WH, Wo NC, Chan WY. J Med Chem; 1995 May 12; 38(10):1762-9. PubMed ID: 7752199 [Abstract] [Full Text] [Related]